You are here
,

FDA advisory panel split over Sanofi-Lexicon diabetes drug

  • Tuesday, 22 January 2019
  • Posted by Aftab Ahmad
  • 0 Comments
An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.


from Reuters: Health News https://reut.rs/2Hkzz72

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply